Follistatin like 5

FSTL5
Identifiers
Aliases	FSTL5, follistatin like 5
External IDs	MGI: 2442179 HomoloGene: 10584 GeneCards: FSTL5
Gene location (Human)
Chr.	Chromosome 4 (human)[1]
End	162,164,004 bp[1]
Gene location (Mouse)
Chr.	Chromosome 3 (mouse)[2]
End	76,617,326 bp[2]
RNA expression pattern
	Top expressed in
	cerebellar vermis; ; endothelial cell; ; pons; ; cerebellar hemisphere; ; superior vestibular nucleus; ; Brodmann area 23; ; ganglionic eminence; ; Brodmann area 46; ; islet of Langerhans; ; middle temporal gyrus;
	Top expressed in
	olfactory epithelium; ; habenula; ; lateral hypothalamus; ; dorsomedial hypothalamic nucleus; ; dorsal tegmental nucleus; ; ventral tegmental area; ; superior colliculus; ; olfactory bulb; ; mammillary body; ; piriform cortex;
	More reference expression data
	n/a
Orthologs
	56884
	213262
	ENSG00000168843
	ENSMUSG00000034098
	Q8N475
	Q8BFR2
	NM_001128427; NM_001128428; NM_020116
	NM_001253719; NM_178673
	NP_001121899; NP_001121900; NP_064501
	NP_001240648; NP_848788
	Wikidata
View/Edit Human	View/Edit Mouse

Follistatin like 5 is a protein that in humans is encoded by the FSTL5 gene. [5]

References

GRCh38: Ensembl release 89: ENSG00000168843 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000034098 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: Follistatin like 5". Retrieved 2017-02-26.

Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR (2010). "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score". Mol. Med. 16 (7–8): 247–53. doi:10.2119/molmed.2009.00159. PMC 2896464. PMID 20379614.
Remke M, Hielscher T, Korshunov A, Northcott PA, Bender S, Kool M, Westermann F, Benner A, Cin H, Ryzhova M, Sturm D, Witt H, Haag D, Toedt G, Wittmann A, Schöttler A, von Bueren AO, von Deimling A, Rutkowski S, Scheurlen W, Kulozik AE, Taylor MD, Lichter P, Pfister SM (2011). "FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma". J. Clin. Oncol. 29 (29): 3852–61. doi:10.1200/JCO.2011.36.2798. PMID 21911727.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.